|
Luteolin for treatment of neuromuscular movement disorder dystonia 16 (DYT16)
Reference #: 01544
The University of South Carolina is offering licensing opportunities for Luteolin for treatment of neuromuscular movement disorder dystonia 16 (DYT16)
Background:
DYT16 is a rare movement disorder, so the number of patients worldwide is small. However, Alzheimer's disease, Down syndrome are very prevalent and large numbers...
Published: 6/13/2024
|
Updated: 1/13/2022
|
Inventor(s): Rekha Patel
Keywords(s): anti-inflammatory pharma, dystonia, DYT16, inflammation, movement disorder, PACT, PKR
Category(s): Biomedical and Life Sciences, Health Sciences
|